Cloning and expression of ornithine decarboxylase gene from human colorectal carcinoma

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 714-716

  Hu, Hai Yan ^a   Liu, Xian Xi ^a   Jiang, Chun Ying ^b   Zhang, Yan ^a   Bian, Ji Feng ^a   Lu, Yi ^a   Geng, Zhao ^a   Liu, Shi Lian ^a   Liu, Chuan Hua ^a   Wang, Xiao Ming ^a   Wang, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

^b Qilu Hospital of Shandong University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; HYBRID PROTEIN; ORNITHINE DECARBOXYLASE; PLASMID DNA; PRIMER DNA; RNA;

ARTICLE; CANCER TISSUE; CELL CLONING; COLORECTAL CANCER; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DNA PURIFICATION; DNA SEQUENCE; EARLY DIAGNOSIS; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION; GENE LOCATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; PROKARYOTE; PROTEIN EXPRESSION; RESTRICTION SITE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

EID: 0038639112     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.714     Document Type: Article

References (35)

1. Jeevanandam M, Petersen SR. Clinical role of polyamine analysis: Problem and promise. Curr Opin Clin Nutr Metab Care 2001; 4: 385-390
2. Auvinen M. Cell transformation, invasion, and angiogenesis: A regulatory role for ornithine decarboxylase. J Natl Cancer Inst 1997; 85: 533-537
3. Bowlin TL, McKown BJ, Davis GF, Sunkara PS. Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice. Cancer Res 1986; 46: 5494-5498
4. Umar A, Viner JL, Hawk ET. The future of colon cancer prevention. Ann N Y Acad Sci 2001; 952: 88-108
5. Rozhin J, Wilson PS, Bull AW, Nigro ND. Ornithine decarboxylase activity in the rat and human colon. Cancer Res 1984; 44: 3226-3230
6. Hixson LJ, Garewal HS, McGee DL, Sloan D, Fennerty MB, Sampliner RE, Gerner EW. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa. Cancer Epidemiol Biomarkers Prev 1993; 2: 369-374
7. Giardiello FM, Hamilton SR, Hylind LM, Yang VW, Tamez P, Casero RA Jr. Ornithine decarboxylase and polyamines in familial adenomatous polyposis. Cancer Res 1997; 57: 199-201
8. Pegg AE, Shantz LM, Coleman CS. Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem (Suppl.) 1995; 22: 132-138
9. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: Molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001; 58: 244-258
10. Wallon UM, Persson L, Heby O. Regulation of ornithine decarboxylase during cell growth. Changes in the stability and translatability of the mRNA, and in the turnover of the protein. Mol Cell Biochem 1995; 146: 39-44
11. Seiler N, Atanassov CL, Raul F. Polyamine metabolism as target for cancer chemoprevention (review). Raul F Int J Oncol 1998; 13: 993-1006
12. Kingsnorth AN, Wallace HM. Elevation of monoacetylated polyamines in human breast cancers. Eur J Cancer Clin Oncol 1985; 21: 1057-1062
13. Wallace HM, Caslake R. Polyamines and colon cancer. Eur J Gastroenterol Hepatol 2001; 13: 1033-1039
14. Faaland CA, Thomas TJ, Balahadrapathruni S, Langer R, Mian S, Shirahata A, Gallo MA, Thomas T. Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis. Biochem Cell Biol 2000; 78: 415-426
15. Canizares F, Salinas J, De Las Heras M, Diaz J, Tovar I, Martinez, P, Penafiel R. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: Correlation with clinicopathologic parameters. Clin Cancer Res 1999; 5: 2035-2041
16. Linsalata M, Caruso MG, Leo S, Guerra V, D'Attoma B, Di Leo A. Prognostic value of tissue polyamine levels in human colorectal carcinoma. Anticancer Res 2002; 22: 2465-2469
17. Takami H, Koudaira H, Kodaira S. Relationship of ornithine decarboxylase activity and human colon tumorigenesis. Jpn J Clin Oncol 1994; 24: 141-143
18. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986; 234: 249-262
19. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128
20. Bello-Fernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A 1993; 90: 7804-7808
21. Packham G, Cleveland JL. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 1994; 14: 5741-5747
22. Iyengar RV, Pawlik CA, Krull EJ, Phelps DA, Burger RA, Harris LC, Potter PM, Danks MK. Use of a modified ornithine decarboxylase promoter to achieve efficient c-YMC- or N-MYC-regulated protein expression. Cancer Res 2001; 61: 3045-3052
23. Kahana C, Nathans D. Translational regulation of mammalian ornithine decarboxylase by polyamines. J Biol Chem 1985; 260: 15390-15393
24. Shantz LM, Pegg AE. Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. Int J Biochem Cell Biol 1999; 31: 107-122
25. Lu L, Stanley BA, Pegg AE. Identification of residues in ornithine decarboxylase essential for enzymic activity and for rapid protein turnover. Biochem J 1991; 277: 671-675
26. Dircks L, Grens A, Slezynger TC, Scheffler IE. Post-transcriptional regulation of ornithine decarboxylase activity. J Cell Physiol 1986; 126: 371-378
27. Heller JS, Fong WF, Canellakis ES. Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Proc Nat Acad Sci USA 1976; 73: 1858-1862
28. Fogel-Petrovic M, Vujcic S, Miller J, Porter CW. Differential post-transcriptional control of ornithine decarboxylase and spermidine-spermine N1-acetyltransferase by polyamines. FEBS Lett 1996; 391: 89-94
29. Ruhl KK, Pomidor MM, Rhim JS, Tuan RS, Hickok NJ. Post-transcriptional suppression of human ornithine decarboxylase gene expression by phorbol esters in human keratinocytes. J Invest Dermatol 1994; 103: 687-692
30. Flamigni F, Campana G, Carboni L, Rossoni C, Spampinato S. Post-transcriptional inhibition of ornithine decarboxylase induction by zinc in a difluoromethylornithine resistant cell line. Biochim Biophys Acta 1994; 1201: 101-105
31. Thompson HJ, Ronan AM. Effect of D,L-2-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 1986; 7: 2003-2006
32. Nigro ND, Bull AW, Boyd ME. Inhibition of intestinal carcinogenesis in rats: Effect of difluoromethylornithine with piroxicam or fish oil. J Natl Cancer Inst 1986; 77: 1309-1313
33. Loprinzi CL, Messing EM, O'Fallon JR, Poon MA, Love RR, Quella SK, Trump DL, Morton RF, Novotny P. Toxicity evaluation of difluoromethylornithine: Doses for chemoprevention trials. Cancer Epidemiol Biomarkers Prev 1996; 5: 371-374
34. Carbone PP, Douglas JA, Larson PO, Verma AK, Blair IA, Pomplun M, Tutsch KD. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. Cancer Epidemiol Biomarkers Prev 1998; 7: 907-912
35. Love RR, Carbone PP, Verma AK, Gilmore D, Carey P, Tutsch KD, Pomplun M, Wilding G. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine. J Natl Cancer Inst 1993; 85: 732-737